Clinical Trial Update: A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pyrotinib plus vinorelbine in HER2-positive metastatic breast cancer patients with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Breast Cancer, Brain Metastases | Phase 2 | Status: UNKNOWN